凯盛新材(301069) - 2021 Q4 - 年度财报

Financial Performance - The company's operating revenue for 2021 was ¥879,591,549.14, representing a 40.95% increase compared to ¥624,026,860.13 in 2020[25] - The net profit attributable to shareholders for 2021 was ¥193,379,071.90, which is a 20.50% increase from ¥160,480,613.99 in 2020[25] - The net profit after deducting non-recurring gains and losses was ¥179,772,058.36, up 13.91% from ¥157,818,314.46 in 2020[25] - The total assets at the end of 2021 reached ¥1,422,613,681.07, a 57.40% increase from ¥903,824,701.09 at the end of 2020[25] - The net assets attributable to shareholders increased by 59.84% to ¥1,275,044,067.68 at the end of 2021 from ¥797,702,313.28 at the end of 2020[25] - The basic earnings per share for 2021 was ¥0.5148, reflecting a 15.69% increase from ¥0.4450 in 2020[25] - The net cash flow from operating activities decreased by 36.66% to ¥88,631,424.00 in 2021 from ¥139,935,143.91 in 2020[25] - The weighted average return on equity for 2021 was 20.04%, down from 22.04% in 2020[25] Revenue and Sales - The company's total revenue for Q4 was ¥278,042,348.33, showing a significant increase compared to Q1's ¥196,335,886.00[28] - The net profit attributable to shareholders for Q4 was ¥51,711,693.62, which is an increase from Q2's ¥43,433,707.18[28] - The net cash flow from operating activities in Q4 reached ¥38,378,596.53, a notable rise from Q1's ¥17,817,167.60[28] - Chlorosulfonic acid revenue reached CNY 295.93 million, accounting for 33.64% of total revenue, with a year-over-year growth of 63.72%[83] - Domestic sales contributed CNY 818.21 million, representing 93.02% of total revenue, with a year-over-year increase of 55.21%[86] Production and Capacity - The company is expanding its production capacity with the new Weifang production base and the mass market introduction of new products like polyether ketone[38] - The production capacity utilization rate for chlorosulfonic acid is 90.02%, with a designed capacity of 150,000 tons per year[67] - The company is in the industrial production stage for key products such as chlorosulfonic acid and aramid polymer monomer, with ongoing technology iterations[67] - The company has initiated trial production for a new project with a capacity of 10,000 tons per year for isophthaloyl chloride, which began in February 2022[69] - The company is expanding its production capabilities with a new project for high-purity 2-propoxyethyl chloride, which is currently in trial production[71] Research and Development - The company has a strong R&D team with 157 personnel, including 3 PhDs and 7 Master's degree holders, focusing on high-end chemical products and has 139 patents, of which 86 are invention patents[45] - The company has established various innovation platforms, including a national postdoctoral research station and a national enterprise technology center, enhancing its R&D capabilities[45] - The company is committed to continuous investment in new product development to ensure the commercialization of research outcomes[45] - The number of R&D personnel increased by 64.52% from 93 in 2020 to 153 in 2021, with R&D personnel accounting for 24.84% of the total workforce[104] - R&D investment amounted to ¥43,096,738.38 in 2021, representing 4.90% of operating revenue, an increase from 4.74% in 2020[104] Market and Sales Strategy - The company has established strong relationships with key clients, including DuPont and Teijin, enhancing its market presence in regions such as China, Japan, South Korea, and the United States[81] - The company is focused on optimizing its production processes and has developed a circular economy model for sulfur dioxide, reducing environmental impact and production costs[78] - The company aims to establish a comprehensive industrial chain from basic chemical raw materials to high-performance polymer materials, targeting four downstream industries: new pigments, new pesticides, new materials, and new energy[140] - The company plans to enhance its product structure and increase production capacity for core products while improving product quality and reducing energy consumption[141] Financial Management - The total investment amount during the reporting period was ¥10,500,000, a 100% increase compared to the same period last year[118] - The company made a significant equity investment of ¥10,500,000 in Shandong Research Institute of High-Performance Materials, acquiring a 35% stake[118] - The company reported a loss of ¥133,678.88 from the investment in Shandong Research Institute of High-Performance Materials[118] - The total amount of raised funds was ¥31,020,000, with ¥4,277,100 utilized during the reporting period[123] - The remaining unused raised funds amount to ¥24,008,320, which are temporarily managed as cash[123] Governance and Compliance - The company has established an internal control system to manage risks and ensure normal business operations[154] - The company maintains transparency in information disclosure, adhering to relevant regulations and ensuring fair access to information for all shareholders[155] - The actual controller of the company exercises rights and obligations without occupying company funds or exceeding authority[151] - The company has no significant differences in governance compared to regulations set by the China Securities Regulatory Commission[158] - The company has a complete and independent business operation capability, independent of the controlling shareholder[159] Employee and Management - The total number of employees at the end of the reporting period was 616[199] - The management team includes professionals with advanced degrees and certifications, such as senior engineers and accountants, ensuring a high level of expertise[170] - The company has appointed independent directors with significant experience in finance and law, enhancing governance and oversight[171] - The total remuneration for directors, supervisors, and senior management in 2021 amounted to CNY 5.4499 million, which is linked to their positions and performance evaluations[180] - Wang Jiarong, the Chairman and General Manager, received a pre-tax total remuneration of CNY 1.6483 million in 2021[183]